🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Noctrix Health clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA register with Noctrix Health as lead sponsor. Synced 26 Sep 2026
3Current trials
1Recruiting now
0Drugs in these trials
1Trial register
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Noctrix Health is the lead sponsor of 3 current clinical trials in our USA register. 1 is recruiting patients now. The most common phase is Not applicable. The most-studied condition is Restless Legs Syndrome.

ClinicalTrials.gov trials by status

  • Recruiting133%
  • Active, closed267%

Trials by phase

  • Not applicable267%
  • Observational133%
01

Clinical trials sponsored by Noctrix Health

3 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)
NCT07675109 · ClinicalTrials.gov ↗ · Restless Legs Syndrome (RLS)
Not applicable Recruiting 2026-06 USA
A Post-Market Study for Long-Term Effectiveness and Safety of the TOMAC System for RLS
NCT06076499 · ClinicalTrials.gov ↗ · Restless Legs Syndrome
Observational Active, closed 2023-11 USA
Response to an Investigational Device in Patients With Restless Legs Syndrome
NCT06866132 · ClinicalTrials.gov ↗ · Restless Legs Syndrome
Not applicable Active, closed 2025-03 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Noctrix Health trials

2 conditions
Restless Legs Syndrome2Restless Legs Syndrome (RLS)1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in USA31

A trial with sites in more than one country appears in each of those registers.

04

Questions about Noctrix Health trials

How many clinical trials does Noctrix Health sponsor?

Noctrix Health is the lead sponsor of 3 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Noctrix Health trials recruiting?

Yes. 1 of its 3 ClinicalTrials.gov trials is recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.